Skip to content

ONCO-HEM: what changed

What changed

ONCO-HEM

BE 0862.730.371
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€97,574
2024 · €73,902+€23,672
Equity
€450,777
2024 · €456,203-€5,426
Cash
€201,112
2024 · €102,171+€98,941
Balance sheet total
€511,591
2024 · €463,228+€48,363

Largest movements

2024 to 2025
Assets
  • Cash +€98,941

    up €98,941 (+96.8%), from €102,171 to €201,112

    mainly Net result for the year (+€97,574) and Receivables within one year (+€44,931)

  • Receivables within one year -€44,931

    no longer reported in 2025 (was €44,931)

  • Tangible fixed assets -€11,767

    down €11,767 (-18.2%), from €64,768 to €53,001

    of which Plant, machinery and equipment: -€12,518

  • Deferred charges and accrued income +€6,120

    up €6,120 (+552%), from €1,108 to €7,227

Equity and liabilities
  • Profit (loss) carried forward -€67,426

    down €67,426 (-33.6%), from €200,643 to €133,217

  • Reserves +€62,000

    up €62,000 (+24.9%), from €249,360 to €311,360

  • Other debts +€29,350

    up €29,350 (+1,468%), from €2,000 to €31,350

  • Debts after one year +€15,343

    new in 2025: €15,343

Income statement
  • Gross operating margin +€15,345

    up €15,345 (+10.3%), from €148,608 to €163,953

  • Other operating charges -€7,902

    down €7,902 (-69.1%), from €11,435 to €3,534

  • Taxes -€2,583

    down €2,583 (-5.6%), from €45,906 to €43,323

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €73,902
Gross operating margin +€15,345
Depreciation -€1,306
Other operating charges +€7,902
Financial income -€333
Financial charges -€518
Taxes +€2,583
Result 2025 €97,574
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€191,482
Investment -€4,883
Financing -€87,657
Cash 2024 €102,171
Net result for the year +€97,574
Depreciation +€16,650
Receivables within one year +€44,931
Deferred charges and accrued income -€6,120
Trade debts +€4,548
Tax, wage and social debts +€4,548
Other debts +€29,350
Investment in fixed assets (net) -€4,883
Debts after one year +€15,343
Contributions, distributions and other -€103,000
Cash 2025 €201,112
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €463,228 €511,591 +€48,363 +10.4%
Fixed assets 21/28 €65,018 €53,251 -€11,767 -18.1%
Tangible fixed assets 22/27 €64,768 €53,001 -€11,767 -18.2%
Plant, machinery and equipment 23 €57,448 €44,930 -€12,518 -21.8%
Furniture and vehicles 24 €7,320 €8,072 +€751 +10.3%
Financial fixed assets 28 €250 €250 = 0.0%
Current assets 29/58 €398,209 €458,339 +€60,130 +15.1%
Amounts receivable within one year 40/41 €44,931 - -€44,931
Other amounts receivable 41 €44,931 - -€44,931
Current investments 50/53 €250,000 €250,000 = 0.0%
Cash at bank and in hand 54/58 €102,171 €201,112 +€98,941 +96.8%
Deferred charges and accrued income 490/1 €1,108 €7,227 +€6,120 +552%
Total equity and liabilities 10/49 €463,228 €511,591 +€48,363 +10.4%
Equity 10/15 €456,203 €450,777 -€5,426 -1.2%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €249,360 €311,360 +€62,000 +24.9%
Distributable reserves 133 €249,360 €311,360 +€62,000 +24.9%
Profit (loss) carried forward 14 €200,643 €133,217 -€67,426 -33.6%
Amounts payable 17/49 €7,025 €60,814 +€53,789 +766%
Amounts payable after more than one year 17 - €15,343 +€15,343
Other amounts payable 178/9 - €15,343 +€15,343
Amounts payable within one year 42/48 €7,025 €45,472 +€38,447 +547%
Trade debts 44 - €4,548 +€4,548
Suppliers 440/4 - €4,548 +€4,548
Taxes, remuneration and social security 45 €5,025 €9,573 +€4,548 +90.5%
Taxes 450/3 €5,025 €9,573 +€4,548 +90.5%
Other amounts payable 47/48 €2,000 €31,350 +€29,350 +1,468%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,344 €16,650 +€1,306 +8.5%
Other operating charges 640/8 €11,435 €3,534 -€7,902 -69.1%
Gross operating margin 9900 €148,608 €163,953 +€15,345 +10.3%
Operating profit (loss) 9901 €121,828 €143,769 +€21,941 +18.0%
Financial income 75/76B €758 €425 -€333 -44.0%
Recurring financial income 75 €758 €425 -€333 -44.0%
Financial charges 65/66B €2,779 €3,297 +€518 +18.7%
Recurring financial charges 65 €2,779 €3,297 +€518 +18.7%
Profit (loss) for the period before taxes 9903 €119,808 €140,897 +€21,089 +17.6%
Income taxes 67/77 €45,906 €43,323 -€2,583 -5.6%
Profit (loss) for the period 9904 €73,902 €97,574 +€23,672 +32.0%
Profit (loss) for the period to be appropriated 9905 €73,902 €97,574 +€23,672 +32.0%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.